Dynasore: Practical Guidance for Dynamin GTPase Inhibition in Endocytosis Research

What This Product Solves

Dynasore (CAS No. 304448-55-3) is a cell-permeable, non-competitive inhibitor of the dynamin family GTPases. These GTPases—primarily dynamin1, dynamin2, and Drp1—are crucial for mediating membrane fission during endocytosis and vesicle trafficking. By blocking dynamin GTPase activity, Dynasore enables researchers to acutely inhibit dynamin-dependent endocytic pathways, such as transferrin uptake in HeLa cells (product_spec). This reversible inhibition provides a controlled experimental tool for dissecting the mechanistic role of dynamin in processes including synaptic vesicle endocytosis inhibition, intracellular trafficking, and signal transduction pathway study, particularly in neuronal and cancer research models. Dynasore is not suitable for inhibition of non-dynamin-mediated processes or as a substitute for genetic knockout approaches.

Protocol Parameters

• assay: Dynamin GTPase inhibition | value_with_unit: IC50 ≈ 15 µM | applicability: Determining effective concentration for acute inhibition in cellular assays | rationale: Establishes dose for robust, reversible blockade of dynamin-mediated endocytosis | source_type: product_spec
• assay: Stock solution preparation | value_with_unit: ≥16.12 mg/mL in DMSO | applicability: Achieving complete dissolution for accurate dosing | rationale: Ensures proper solubilization; water and ethanol are unsuitable solvents | source_type: product_spec
• assay: Storage conditions for stock | value_with_unit: -20°C | applicability: Preserving compound integrity before use | rationale: Reduces risk of degradation; avoid repeated freeze-thaw cycles and long-term storage of diluted solutions | source_type: product_spec
• assay: Dissolution enhancement | value_with_unit: Warming to 37°C or ultrasonic shaking | applicability: Facilitates rapid and complete solubilization in DMSO | rationale: Addresses potential for incomplete dissolution at room temperature | source_type: product_spec

Workflow Setup and QC Checklist

• Use DMSO as the solvent for Dynasore. Confirm complete dissolution visually; employ warming (37°C) or brief sonication if undissolved material persists.
• Prepare fresh working solutions immediately before use. Avoid storing diluted solutions long-term, as stability beyond short-term use is not established (product_spec).
• Apply Dynasore at empirically validated concentrations (typically 10–80 µM, with IC50 ≈ 15 µM as a reference for dynamin inhibition efficacy). Confirm functional inhibition using established markers, such as blocked transferrin uptake or impaired vesicle formation (related_article).
• Include DMSO-only controls to distinguish specific inhibition from solvent effects.
• Monitor cell viability under Dynasore treatment, as off-target toxicity is possible at higher concentrations or prolonged exposures.
• Document batch number and storage date for all prepared stocks.

Common Failure Modes and Fixes

• Incomplete inhibition of endocytosis: Confirm use of DMSO as the solvent and verify final Dynasore concentration matches protocol requirements. Ensure the compound is fully dissolved and freshly prepared to avoid degradation.
• Precipitate formation in working solution: Warm the DMSO stock to 37°C and vortex or sonicate briefly. Discard any samples with visible precipitate after attempted resuspension, as incomplete solubilization may compromise results.
• Reduced efficacy upon repeated freeze-thaw: Aliquot Dynasore stocks to minimize freeze-thaw cycles. Discard aliquots after one freeze-thaw if performance issues are observed (product_spec).
• Apparent off-target effects or cytotoxicity: Titrate Dynasore concentration downward and include DMSO-only and untreated controls. Shorten incubation time if necessary to reduce non-specific effects (related_article).
• Loss of inhibitory activity over time: Avoid storing diluted Dynasore solutions. Prepare fresh working solutions for each experiment to maintain activity.

Scope and Limitations

Dynasore provides reversible, non-competitive inhibition of dynamin GTPases in live-cell and fixed-cell assays, supporting studies in endocytosis research, synaptic vesicle endocytosis inhibition, and signal transduction pathway study. Its application is best suited for acute, short-term inhibition of dynamin-dependent endocytosis. It is not recommended for use in water- or ethanol-based systems due to insolubility, nor for long-term studies requiring stable compound activity over days. The compound does not inhibit endocytosis mediated by non-dynamin pathways and should not be used as a universal endocytosis inhibitor. Off-target effects and cytotoxicity at high concentrations or prolonged exposures should be carefully controlled and reported.

Conclusion

Dynasore (SKU A1605) is a practical, well-characterized tool for acute inhibition of dynamin-mediated endocytosis and vesicle trafficking in cellular models. Its reversible, dose-dependent action allows for precise temporal control of dynamin GTPase activity with established protocols for solubilization, application, and quality control (Dynasore). For additional protocol guidance and mechanistic background, see related articles on the specificity and workflow integration of dynamin GTPase inhibitors (internal_article; internal_article). Researchers should validate Dynasore performance in their specific assay context, monitor for non-specific effects, and adhere to recommended storage and handling practices for optimal results.